{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:10:24Z","timestamp":1789773024325,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.htct.2023.08.006","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T08:44:48Z","timestamp":1697013888000},"page":"420-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes and challenges treating pediatric acute myeloid leukemia: a retrospective analysis of patients treated at the Fundaci\u00f3n Valle del Lili between 2011 and 2020"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3173-6059","authenticated-orcid":false,"given":"Alexis A.","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-409X","authenticated-orcid":false,"given":"Viviana","family":"Lotero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6217-2065","authenticated-orcid":false,"given":"Pamela","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-8356","authenticated-orcid":false,"given":"Estefania","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5577-970X","authenticated-orcid":false,"given":"Eliana","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1845-9082","authenticated-orcid":false,"given":"Angela","family":"Devia-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1465-7957","authenticated-orcid":false,"given":"Diego","family":"Medina-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2023.08.006_bib0001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/1-4020-7920-6_3","article-title":"Relevance of pathologic classifications and diagnosis of acute myeloid leukemia to clinical trials and clinical practice","volume":"121","author":"Tallman","year":"2004","journal-title":"Cancer Treat Res"},{"issue":"2","key":"10.1016\/j.htct.2023.08.006_bib0002","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5935\/1676-2444.20150013","article-title":"Frequency of acute myeloid leukemia in children attended in Bel\u00e9m, Par\u00e1 from August 2005 to May 2009","volume":"51","author":"Brito","year":"2015","journal-title":"J Bras Patol e Med Lab"},{"issue":"2","key":"10.1016\/j.htct.2023.08.006_bib0003","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.seminhematol.2018.08.002","article-title":"The 2016 WHO classification of acute myeloid leukemia: what the practicing clinician needs to know","volume":"56","author":"Arber","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.htct.2023.08.006_bib0004","article-title":"Gu\u00eda de Pr\u00e1ctica Cl\u00ednica Para La Detecci\u00f3n Oportuna, Diagn\u00f3stico y Seguimiento de Leucemia Linfoide Aguda y Leucemia Mieloide Aguda En Ni\u00f1os","volume":"9","year":"2013","journal-title":"Ni\u00f1as y Adolescentes"},{"key":"10.1016\/j.htct.2023.08.006_bib0005","unstructured":"Instituto Nacional de Salud. C\u00e1ncer en menores de 18 A\u00f1os. Protoc en Vigil en salud publica. Published online 2021:2. https:\/\/www.ins.gov.co\/buscador-eventos\/Lineamientos\/PRO-C\u00e1ncer-en-menores-de-18-a\u00f1os-.pdf"},{"key":"10.1016\/j.htct.2023.08.006_bib0006","unstructured":"Ramirez O. Informaci\u00f3n y C\u00e1ncer infantil. Sistema de Vigilancia Epidemiol\u00f3gica de C\u00e1ncer Pedi\u00e1trico (VIGICANCER), Cali, Colombia. Published 2016. Accessed December 22, 2022. https:\/\/colombiamedica.univalle.edu.co\/index.php\/comedica\/article\/download\/2374\/2856?inline=1"},{"issue":"12B","key":"10.1016\/j.htct.2023.08.006_bib0007","first-page":"2316","article-title":"Mortality in paediatric acute myeloid leukaemia","volume":"70","author":"Ghafoor","year":"2020","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.htct.2023.08.006_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0963689720949175","article-title":"Allogeneic hematopoietic stem cell transplantation for children and adolescents with acute myeloid leukemia in Brazil: a multicentric retrospective study","volume":"29","author":"de Melo Rodrigues","year":"2020","journal-title":"Cell Transplant"},{"issue":"4","key":"10.1016\/j.htct.2023.08.006_bib0009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/14737140.2021.1860763","article-title":"Measurable residual disease in pediatric acute myeloid leukemia: a systematic review","volume":"21","author":"Segerink","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"issue":"7","key":"10.1016\/j.htct.2023.08.006_bib0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/14737140.2021.1895756","article-title":"Outcome of pediatric acute myeloid leukemia (AML) in low- and middle-income countries: a systematic review of the literature","volume":"21","author":"Van Weelderen","year":"2021","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.htct.2023.08.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.retram.2022.103360","volume":"71","author":"Cao","year":"2022","journal-title":"Curr Res Transl Med"},{"issue":"9","key":"10.1016\/j.htct.2023.08.006_bib0012","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbmt.2017.05.025","article-title":"Reduced-intensity conditioning with Busulfan, Fludarabine, and antithymocyte globulin for hematopoietic cell transplantation from unrelated or haploidentical family donors in patients with acute myeloid leukemia in remission","volume":"23","author":"Lee","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.htct.2023.08.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29087","article-title":"Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies","volume":"68","author":"Rossoff","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.htct.2023.08.006_bib0014","first-page":"1","article-title":"Unrelated cord blood transplantation versus haploidentical transplantation in adult and pediatric patients with hematological malignancies-a meta-analysis and systematic review","volume":"10","author":"Li","year":"2020","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.htct.2023.08.006_bib0015","unstructured":"The World Bank Group. World Bank Country and Lending Groups."},{"issue":"4","key":"10.1016\/j.htct.2023.08.006_bib0016","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.seminhematol.2016.08.001","article-title":"Selecting the best haploidentical donor","volume":"53","author":"McCurdy","year":"2016","journal-title":"Semin Hematol"},{"issue":"12","key":"10.1016\/j.htct.2023.08.006_bib0017","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.htct.2023.08.006_bib0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rccan.2018.05.004","article-title":"Trasplante de c\u00e9lulas madre hematopoy\u00e9ticas en pacientes pedi\u00e1tricos con diagn\u00f3stico de neoplasias mieloides, experiencia en 15 a\u00f1os","volume":"22","author":"Medina","year":"2018","journal-title":"Rev Colomb Cancerol"},{"issue":"5","key":"10.1016\/j.htct.2023.08.006_bib0019","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbmt.2018.01.005","article-title":"Sequential conditioning with thiotepa in T cell- replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with matched related, haplo-mismatched, and unrelated donors","volume":"24","author":"Dul\u00e9ry","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.htct.2023.08.006_bib0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3324\/haematol.2016.150326","article-title":"Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia","volume":"102","author":"Mohty","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.htct.2023.08.006_bib0021","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbmt.2014.08.014","article-title":"Post-transplant high-dose cyclophosphamide for the prevention of graft-versus-host disease","volume":"21","author":"Al-Homsi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.htct.2023.08.006_bib0022","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ajh.20710","article-title":"Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor","volume":"81","author":"Kanda","year":"2006","journal-title":"Am J Hematol"},{"issue":"09","key":"10.1016\/j.htct.2023.08.006_bib0023","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"Onis","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"9","key":"10.1016\/j.htct.2023.08.006_bib0024","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.bbmt.2015.05.019","article-title":"Establishment of definitions and review process for consistent adjudication of cause-specific mortality after allogeneic unrelated-donor hematopoietic cell transplantation","volume":"21","author":"Hahn","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.htct.2023.08.006_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.35509\/01239015.16","article-title":"Mejor\u00eda en la supervivencia de los ni\u00f1os con leucemia mieloide aguda en el Instituto Nacional de Cancerolog\u00eda de Colombia","volume":"24","author":"Suarez Matos","year":"2020","journal-title":"Rev Colomb Cancerol"},{"issue":"5","key":"10.1016\/j.htct.2023.08.006_bib0026","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2141.2010.08389.x","article-title":"Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003","volume":"151","author":"Molgaard-Hansen","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.htct.2023.08.006_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28099","article-title":"Causes of early death and treatment-related death in newly diagnosed pediatric acute myeloid leukemia: recent experiences of the Dutch Childhood Oncology Group","volume":"67","author":"Klein","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.htct.2023.08.006_bib0028","first-page":"340","article-title":"High infection-related mortality in pediatric acute myeloid leukemia without preventive antibiotics and antifungals: retrospective cohort study of a single center from a middle-income country","volume":"34","author":"Zengin","year":"2017","journal-title":"Turkish J Hematol"},{"issue":"9","key":"10.1016\/j.htct.2023.08.006_bib0029","first-page":"1","article-title":"Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial","volume":"12","author":"Radhakrishnan","year":"2022","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.htct.2023.08.006_bib0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1182\/bloodadvances.2020003709","article-title":"Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets","volume":"5","author":"Stratmann","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.htct.2023.08.006_bib0031","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11912-020-01009-3","article-title":"Acute myeloid leukemia in children: emerging paradigms in genetics and new approaches to therapy","volume":"23","author":"Conneely","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.htct.2023.08.006_bib0032","doi-asserted-by":"crossref","unstructured":"Quessada J, Cuccuini W, Saultier P, Loosveld M, Harrison CJ, Lafage-Pochitaloff M. Cytogenetics of pediatric acute myeloid leukemia: a review of the current knowledge. Vol 12; 2021. doi:10.3390\/genes12060924","DOI":"10.3390\/genes12060924"},{"issue":"3","key":"10.1016\/j.htct.2023.08.006_bib0033","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/nsr\/nwz006","article-title":"Ecological principle meets cancer treatment: Treating children with acute myeloid leukemia with low-dose chemotherapy","volume":"6","author":"Hu","year":"2019","journal-title":"Natl Sci Rev"},{"issue":"2","key":"10.1016\/j.htct.2023.08.006_bib0034","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/children8020109","article-title":"Treatment outcomes of pediatric acute myeloid leukemia in the Yeungnam Region: a multicenter retrospective study of the Study Alliance of Yeungnam Pediatric Hematology\u2013Oncology (SAYPH)","volume":"8","author":"Lee","year":"2021","journal-title":"Children"},{"issue":"S1","key":"10.1016\/j.htct.2023.08.006_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5045\/br.2020.S002","article-title":"Treatments for children and adolescents with AML","volume":"55","author":"Kim","year":"2020","journal-title":"Blood Res"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792302552X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S253113792302552X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:37:17Z","timestamp":1726612637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S253113792302552X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S253113792302552X"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.08.006","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and challenges treating pediatric acute myeloid leukemia: a retrospective analysis of patients treated at the Fundaci\u00f3n Valle del Lili between 2011 and 2020","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}